Clinical Trials Logo

Malignant Tumour clinical trials

View clinical trials related to Malignant Tumour.

Filter by:
  • Suspended  
  • Page 1

NCT ID: NCT04125524 Suspended - Malignant Tumour Clinical Trials

Terahertz Metamaterials for Tumour Marker Concentration Identification

Start date: May 17, 2021
Phase:
Study type: Observational

The research the investigators plan to undertake involves the use of a metamaterial at terahertz frequencies. Serum samples will be tested using the metamaterial to determine if this method can be used to measure the concentration of tumour markers present in the sample. Patients who have been tested for CEA, LDH, CA-125, CA 19-9, CA 15-3, total-hCG and AFP will be used for both the positive and negative samples.